Sort
130,381 grants matching “hiv”
Identification of the Initial Targets of Transmission
$793,398Thomas Hope · Northwestern University At Chicago · R37 · FY2019 · AI
Pathogenomics of Chlamydial Infection
$793,353Harlan D Caldwell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
The effect of HIV exposure and infection on immunity to TB in children
$793,352Grace C John-Stewart · University Of Washington · R01 · FY2020 · AI
Novel Mucosal Adjuvant for an HIV DNA Vaccine
$793,348Kenneth C Bagley · Profectus Biosciences, Inc. · R44 · FY2017 · AI
Thwarting HIV evasion of antibody avidity with novel antibody architectures
$793,342Pamela J Bjorkman · California Institute Of Technology · DP1 · FY2013 · DA
Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV
$793,338Rafick-Pierre Sekaly · Emory University · R37 · FY2023 · AI
Leveraging Social Networks to Increase COVID-19 Testing Uptake: A Comparison of Credible Messenger and Chain Referral Recruitment Approaches
$793,293Katherine S Elkington · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · UG1 · FY2021 · DA
Handheld and population-based sequencing for rapid detection of new and repurposed drug resistance in M. tuberculosis
$793,285John Zapata Metcalfe · University Of California, San Francisco · R01 · FY2021 · AI
HIV-related Accelerated Aging of the Airway Epithelium
$793,263Ronald G Crystal · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · HL
Data science and epidemiology to improve health of people with HIV
$793,247Sonia Napravnik · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AI
B positive_A population based evaluation of expanded ART access in pregnancy
$793,230Andrew Marc Boulle · University Of Cape Town · R01 · FY2017 · HD
Supramolecular pediatric HIV vaccine design
$793,206Genevieve Giny Fouda Amou Ou · Duke University · R01 · FY2019 · AI
Defining the Immunogenicity and Efficacy of a Durable BCG Vaccine Strategy Optimized for Preventing TB in Pediatric HIV Infection
$793,149Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
Impact of NETosis on SIV Pathogenesis and Response to Treatment
$793,137Ivona Pandrea · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · HL
Impact of NETosis on SIV Pathogenesis and Response to Treatment
$793,137Ivona Pandrea · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL
Motivating HIV+ Women: Risk Reduction and ART Adherence
$793,135Emory University · R01 · FY2004 · NR
The Spinal Cord as a CNS Latent Reservoir for Replication Competent SIV
$793,116Joseph L Mankowski · Johns Hopkins University · R01 · FY2020 · NS
Translational Research: Host-Pathogen Interactions in Patient Fungal Diseases
$793,108Peter Williamson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Molecular Pathobiology of Cryptococcus neoformans
$793,108Peter Williamson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Tirzepatide for treatment of familial partial lipodystrophy
$793,098Elif Arioglu Oral · University Of Michigan At Ann Arbor · R01 · FY2025 · DK
Impact of microbiota on AIDS-Kaposiâs sarcoma development and therapy
$793,089Shou-Jiang Gao · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Preclinical studies of a Cryptococcus vaccine for AIDS patients
$793,078Jennifer K. Lodge · Duke University · R01 · FY2024 · AI
Preclinical studies of a Cryptococcus vaccine for AIDS patients
$793,078Jennifer K. Lodge · Duke University · R01 · FY2023 · AI
Understanding the mechanisms involved in HIV-1 CNS latency
$793,032Velpandi Ayyavoo · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · MH
MSMW: Pathways, Motives and Behaviors
$793,021Karolynn Siegel · Columbia University Health Sciences · R01 · FY2007 · MH